NDSN(NDSN)
NDSN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.98B | $3.14B | $3.29B |
| Low | $2.97B | $3.13B | $3.23B |
| High | $2.99B | $3.15B | $3.39B |
| EBITDA Avg | $932M | $981M | $1.03B |
| Low | $926M | $978M | $1.01B |
| High | $935M | $985M | $1.06B |
| EBIT Avg | $758M | $799M | $837M |
| Low | $754M | $796M | $822M |
| High | $761M | $802M | $861M |
| Net Income Avg | $661M | $718M | $764M |
| Low | $655M | $702M | $755M |
| High | $666M | $733M | $774M |
| EPS Avg | $11.60 | $12.60 | $13.43 |
| Low | $11.51 | $12.34 | $13.26 |
| High | $11.70 | $12.88 | $13.60 |
| Analysts (Rev / EPS) | 6 / 5 | 6 / 5 | 3 / 2 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 | Q3 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $794M | $698M | $775M | $824M | $839M | $731M | $805M | $846M |
| Low | $790M | $695M | $771M | $820M | $835M | $727M | $801M | $841M |
| High | $797M | $703M | $780M | $829M | $844M | $735M | $810M | $851M |
| EBITDA Avg | $248M | $218M | $242M | $257M | $262M | $228M | $251M | $264M |
| Low | $247M | $217M | $241M | $256M | $261M | $227M | $250M | $263M |
| High | $249M | $219M | $244M | $259M | $264M | $230M | $253M | $266M |
| EBIT Avg | $202M | $178M | $197M | $209M | $213M | $186M | $205M | $215M |
| Low | $201M | $177M | $196M | $208M | $212M | $185M | $204M | $214M |
| High | $203M | $179M | $198M | $211M | $215M | $187M | $206M | $216M |
| Net Income Avg | $184M | $143M | $171M | $188M | $200M | $151M | $184M | $202M |
| Low | $183M | $142M | $170M | $187M | $199M | $150M | $182M | $201M |
| High | $185M | $144M | $173M | $190M | $202M | $152M | $185M | $204M |
| EPS Avg | $3.28 | $2.55 | $3.05 | $3.36 | $3.56 | $2.70 | $3.27 | $3.60 |
| Low | $3.26 | $2.53 | $3.03 | $3.33 | $3.54 | $2.68 | $3.25 | $3.58 |
| High | $3.29 | $2.57 | $3.07 | $3.38 | $3.59 | $2.72 | $3.30 | $3.63 |
| Analysts (Rev / EPS) | 4 / 4 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 1 / 2 | 1 / 2 | 1 / 2 |